India to Singapore: Pomalidomide Export Trade Route
India has recorded 9 verified shipments of Pomalidomide exported to Singapore, representing a combined trade value of $20.8K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $2.3K USD. The leading Indian exporter is 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, which accounts for 52% of total export value with 5 shipments worth $10.9K USD. On the buying side, FOR THE ORDER OF is the largest importer in Singapore with $9.1K USD in purchases. The top 3 suppliers — 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED , MUNANI PHARMACEUTICALS — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Singapore Pomalidomide corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $20.8K USD. The route is dominated by 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's pomalidomide manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $2.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with pomalidomide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 23.6%, placing it at rank #2 among India's top pomalidomide export destinations globally.
On the import side, key buyers of Indian pomalidomide in Singapore include FOR THE ORDER OF , FOR THE ORDER OF, NA and 2 others. FOR THE ORDER OF is the single largest importer with 1 shipments valued at $9.1K USD.
Route Characteristics
- Average transit25 days
